| Immediate Hospice Care, Inc 14640 Victory Blvd, Ste 224, Van Nuys, CA, 91411 | |
| (818) 935-1687 |
News Archive
deCODE genetics has announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.
New technology can improve sound quality for hearing implant users by a life-changing amount. Dr Wim Melis from the University of Greenwich is working on deconstructing and reconstructing audio signals with extremely high accuracy.
The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.
› Verified 4 days ago
| Name | Immediate Hospice Care, Inc |
|---|---|
| Location | 14640 Victory Blvd, Ste 224, Van Nuys, California |
| Hospice ID | 751532 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | The Joint Commission (TJC) |
| SSA county code | 200 |
News Archive
deCODE genetics has announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.
New technology can improve sound quality for hearing implant users by a life-changing amount. Dr Wim Melis from the University of Greenwich is working on deconstructing and reconstructing audio signals with extremely high accuracy.
The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.
› Verified 4 days ago
| NPI Number | 1598004863 |
| Organization Name | Immediate Hospice Care |
| Address | 14640 Victory Blvd Van Nuys, California, 91411 |
| Phone Number | (818)997-7633 |
News Archive
deCODE genetics has announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.
New technology can improve sound quality for hearing implant users by a life-changing amount. Dr Wim Melis from the University of Greenwich is working on deconstructing and reconstructing audio signals with extremely high accuracy.
The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
deCODE genetics has announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.
New technology can improve sound quality for hearing implant users by a life-changing amount. Dr Wim Melis from the University of Greenwich is working on deconstructing and reconstructing audio signals with extremely high accuracy.
The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.
› Verified 4 days ago
| Home Health Aides | 1 |
| Counselors | 1 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 1 |
| Physicians | 1 |
| Registered Nurses | 2 |
| Total Employees | 7 |
|---|
News Archive
deCODE genetics has announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.
New technology can improve sound quality for hearing implant users by a life-changing amount. Dr Wim Melis from the University of Greenwich is working on deconstructing and reconstructing audio signals with extremely high accuracy.
The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.
› Verified 4 days ago
| Others | 1 |
| Total Volunteers | 1 |
|---|
News Archive
deCODE genetics has announced the launch of deCODE T2, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Anacor Pharmaceuticals announced today that Merck has returned full worldwide development and commercialization rights for AN2690 to Anacor. AN2690 is a topical anti-fungal therapy being developed for onychomycosis, a fungal infection of the nail and nail bed. It is estimated that onychomycosis affects approximately 35 million people in the United States.
New technology can improve sound quality for hearing implant users by a life-changing amount. Dr Wim Melis from the University of Greenwich is working on deconstructing and reconstructing audio signals with extremely high accuracy.
The new Jefferson Vascular Center at Thomas Jefferson University Hospital offers an integrated, multidisciplinary approach to the diagnosis, management and treatment of vascular diseases (diseases of blood vessels) and thrombotic (blood-clotting) disorders all under one roof.
› Verified 4 days ago
| Haga Hospice, Inc Location: 5627 Sepulveda Blvd., Suite 230, Van Nuys, California, 91411 Phone: (818) 935-1687 |
| West Coast Hospice Management, Inc. Location: 13746 Victory Blvd., Ste. 301, Van Nuys, California, 91401 Phone: (818) 935-1687 |
| Helping Hands Hospice Services Location: 7136 Haskell Avenue, Suite 302, Van Nuys, California, 91406 Phone: (818) 935-1687 |
| Heaven Hospice, Inc Location: 14557 Friar St, Ste B1, Van Nuys, California, 91411 Phone: (818) 935-1687 |